Journal of Nutrition EB Program 2010 Early Registration

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimura, Y.
Right arrow Articles by Okuda, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kimura, Y.
Right arrow Articles by Okuda, H.
(Journal of Nutrition. 2001;131:1844-1849.)
© 2001 The American Society for Nutritional Sciences


Articles

Resveratrol Isolated from Polygonum cuspidatum Root Prevents Tumor Growth and Metastasis to Lung and Tumor-Induced Neovascularization in Lewis Lung Carcinoma-Bearing Mice

Yoshiyuki Kimura1 and Hiromichi Okuda

Second Department of Medical Biochemistry, School of Medicine, Ehime University, Shigenobu-cho, Onsen-gun, Ehime 791-0295, Japan

1To whom correspondence should be addressed. E-mail: yokim{at}m.ehime-u.ac.jp.

Resveratrol is a naturally occurring phytoalexine found in medicinal plants. We found that resveratrol, at doses of 2.5 and 10 mg/kg, significantly reduced the tumor volume (42%), tumor weight (44%) and metastasis to the lung (56%) in mice bearing highly metastatic Lewis lung carcinoma (LLC) tumors, but not at a dose of 0.6 mg/kg. Resveratrol did not affect the number of CD4+, CD8+ and natural killer (NK)1.1.+ T cells in the spleen. Therefore, the inhibitory effects of resveratrol on tumor growth and lung metastasis could not be explained by natural killer or cytotoxic T-lymphocyte activation. In addition, resveratrol inhibited DNA synthesis most strongly in LLC cells; its 50% inhibitory concentration (IC50) was 6.8 µmol/L. Resveratrol at 100 µmol/L increased apoptosis to 20.6 ± 1.35% from 12.1 ± 0.36% (P < 0.05) in LLC cells, and decreased the S phase population to 22.1 ± 1.03% and 29.2 ± 0.27% from 35.2 ± 1.72% (P < 0.05) at concentrations of 50 and 100 µmol/L, respectively. Resveratrol inhibited tumor-induced neovascularization at doses of 2.5 and 10 mg/kg in an in vivo model. Moreover, resveratrol significantly inhibited the formation of capillary-like tube formation from human umbilical vein endothelial cells (HUVEC) at concentrations of 10–100 µmol/L; the degree of the inhibition of capillary-like tube formation by resveratrol was 45.5% at 10 µmol/L, 50.2% at 50 µmol/L and 52.6% at 100 µmol/L. Resveratrol inhibited the binding of vascular endothelial growth factor (VEGF) to HUVEC at concentrations of 10–100 µmol/L, but not at concentrations of 1 and 5 µmol/L. The degree of inhibition of VEGF binding to HUVEC by resveratrol was 16.9% at 10 µmol/L, 53.2% at 50 µmol/L and 47.8% at 100 µmol/L. We suggest that the antitumor and antimetastatic activities of resveratrol might be due to the inhibition of DNA synthesis in LLC cells and the inhibition of LLC-induced neovascularization and tube formation (angiogensis) of HUVEC by resveratrol


KEY WORDS: • resveratrol • antitumor activity • antimetastaic activity • angiogenesis • mice




This article has been cited by other articles:


Home page
Cancer Prevention ResearchHome page
E. N. Scott, A. J. Gescher, W. P. Steward, and K. Brown
Development of Dietary Phytochemical Chemopreventive Agents: Biomarkers and Choice of Dose for Early Clinical Trials
Cancer Prevention Research, June 1, 2009; 2(6): 525 - 530.
[Abstract] [Full Text] [PDF]


Home page
Cancer Prevention ResearchHome page
A. Bishayee
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Cancer Prevention Research, May 1, 2009; 2(5): 409 - 418.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Chao, J. M. Slezak, B. J. Caan, and V. P. Quinn
Alcoholic Beverage Intake and Risk of Lung Cancer: The California Men's Health Study
Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2692 - 2699.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. M. Roccaro, X. Leleu, A. Sacco, A.-S. Moreau, E. Hatjiharissi, X. Jia, L. Xu, B. Ciccarelli, C. J. Patterson, H. T. Ngo, et al.
Resveratrol Exerts Antiproliferative Activity and Induces Apoptosis in Waldenstrom's Macroglobulinemia
Clin. Cancer Res., March 15, 2008; 14(6): 1849 - 1858.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Chao
Associations between Beer, Wine, and Liquor Consumption and Lung Cancer Risk: A Meta-analysis
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2436 - 2447.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. Nagaoka, T. W. Hein, A. Yoshida, and L. Kuo
Resveratrol, a Component of Red Wine, Elicits Dilation of Isolated Porcine Retinal Arterioles: Role of Nitric Oxide and Potassium Channels
Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4232 - 4239.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Mohan, A. A. Gandhi, B. C. Bhavya, R. Rashmi, D. Karunagaran, R. Indu, and T. R. Santhoshkumar
Caspase-2 Triggers Bax-Bak-dependent and -independent Cell Death in Colon Cancer Cells Treated with Resveratrol
J. Biol. Chem., June 30, 2006; 281(26): 17599 - 17611.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Boissy, T. L. Andersen, B. M. Abdallah, M. Kassem, T. Plesner, and J.-M. Delaisse
Resveratrol Inhibits Myeloma Cell Growth, Prevents Osteoclast Formation, and Promotes Osteoblast Differentiation
Cancer Res., November 1, 2005; 65(21): 9943 - 9952.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Maeda and Y. Kimura
Antitumor Effects of Various Low-Molecular-Weight Chitosans Are Due to Increased Natural Killer Activity of Intestinal Intraepithelial Lymphocytes in Sarcoma 180-Bearing Mice
J. Nutr., April 1, 2004; 134(4): 945 - 950.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
S.-H. Tseng, S.-M. Lin, J.-C. Chen, Y.-H. Su, H.-Y. Huang, C.-K. Chen, P.-Y. Lin, and Y. Chen
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Clin. Cancer Res., March 15, 2004; 10(6): 2190 - 2202.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. C. Ziegler, L. Rainwater, J. Whelan, and M. F. McEntee
Dietary Resveratrol Does Not Affect Intestinal Tumorigenesis in ApcMin/+ Mice
J. Nutr., January 1, 2004; 134(1): 5 - 10.
[Abstract] [Full Text] [PDF]


Home page
Biol Res NursHome page
D. O. McCarthy
Rethinking Nutritional Support for Persons with Cancer Cachexia
Biol Res Nurs, July 1, 2003; 5(1): 3 - 17.
[Abstract] [PDF]


Home page
J. Nutr.Home page
J. R. Stewart, M. C. Artime, and C. A. O'Brian
Resveratrol: A Candidate Nutritional Substance for Prostate Cancer Prevention
J. Nutr., July 1, 2003; 133(7): 2440S - 2443.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.-H. Oak, M. Chataigneau, T. Keravis, T. Chataigneau, A. Beretz, R. Andriantsitohaina, J.-C. Stoclet, S.-J. Chang, and V. B. Schini-Kerth
Red Wine Polyphenolic Compounds Inhibit Vascular Endothelial Growth Factor Expression in Vascular Smooth Muscle Cells by Preventing the Activation of the p38 Mitogen-Activated Protein Kinase Pathway
Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1001 - 1007.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
Y. Kimura
Carp Oil or Oleic Acid, but Not Linoleic Acid or Linolenic Acid, Inhibits Tumor Growth and Metastasis in Lewis Lung Carcinoma-Bearing Mice
J. Nutr., July 1, 2002; 132(7): 2069 - 2075.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
X. Gao, Y. X. Xu, G. Divine, N. Janakiraman, R. A. Chapman, and S. C. Gautam
Disparate In Vitro and In Vivo Antileukemic Effects of Resveratrol, a Natural Polyphenolic Compound Found in Grapes
J. Nutr., July 1, 2002; 132(7): 2076 - 2081.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. P. Simopoulos
The Mediterranean Diets: What Is So Special about the Diet of Greece? The Scientific Evidence
J. Nutr., November 1, 2001; 131(11): 3065S - 3073.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2001 by American Society for Nutrition